title: Dengue surveillance by proxy: travellers as sentinels for outbreaks in the Pacific Islands.
abstract: Sensitive surveillance systems are crucial for effective control of infectious disease outbreaks, and regional surveillance could provide valuable data to supplement global systems, improve sensitivity and timeliness of reporting, or capture otherwise undetected outbreaks. In New Zealand (NZ), there are no endemic arboviral diseases in humans, and the majority of dengue cases are imported from neighbouring Pacific Islands where comprehensive surveillance systems are under development. From 1997 to 2009, 679 cases of dengue were reported in NZ (74·2% acquired from the Pacific Islands), and the patterns of reported incidence of dengue acquired from different islands closely reflected local reported incidence in those areas. NZ is therefore in a unique position to provide early alerts on dengue outbreaks in the Pacific Islands. Such a strategy would reduce disease burden in both the Pacific Islands and NZ, and provide a model for transnational collaboration in disease surveillance with regional as well as global benefits.
authors: School of Population Health, The University of Queensland, Herston, Queensland, Australia.
authors: C L
authors: CL
authors: Lau
authors: P
authors: P
authors: Weinstein
authors: D
authors: D
authors: Slaney
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D003715:Dengue / Q000453:epidemiology*; D004196:Disease Outbreaks; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010139:Pacific Islands / Q000453:epidemiology; D012189:Retrospective Studies; D018571:Sentinel Surveillance; D014195:Travel; D055815:Young Adult
references: Travel Med Infect Dis. 2003 May;1(2):89-93
references: 17291893
references: Travel Med Infect Dis. 2006 Dec;4(6):319-23
references: 17098627
references: Emerg Infect Dis. 2008 Jul;14(7):1081-8
references: 18598629
references: Nat Rev Microbiol. 2010 Dec;8(12 Suppl):S30-8
references: 21548185
references: J Travel Med. 2006 May-Jun;13(3):145-52
references: 16706945
references: N Engl J Med. 2005 Sep 1;353(9):924-32
references: 16135837
references: Med Clin North Am. 2008 Nov;92(6):1377-90, x
references: 19061757
references: Aust N Z J Public Health. 2003;27(1):82-6
references: 14705274
references: Pac Health Dialog. 2005 Sep;12(2):45-52
references: 18181493
references: Pac Health Dialog. 2005 Sep;12(2):111-9
references: 18181502
references: Curr Infect Dis Rep. 2009 Jan;11(1):51-8
references: 19094825
references: Western Pac Surveill Response J. 2015 Apr 20;6(2):82-9
references: 26306221
references: Int J Antimicrob Agents. 2010 Nov;36 Suppl 1:S40-2
references: 20833000
references: Annu Rev Microbiol. 2008;62:71-92
references: 18429680
references: Environ Health Perspect. 2008 Sep;116(9):A382-8
references: 18795135
references: Lancet Infect Dis. 2004 Mar;4(3):171-7
references: 14998504
references: Emerg Infect Dis. 2010 Jan;16(1):123-5
references: 20031057
references: Travel Med Infect Dis. 2012 May;10(3):129-34
references: 22579017
references: N Engl J Med. 2006 Jan 12;354(2):119-30
references: 16407507
references: Clin Infect Dis. 2002 Nov 1;35(9):1047-52
references: 12384837
references: J Travel Med. 2003 Jul-Aug;10(4):208-13
references: 12946298
references: J Appl Microbiol. 2003;94 Suppl:1S-11S
references: 12675931
references: Curr Infect Dis Rep. 2010 May;12(3):157-64
references: 21308524
references: Lancet Infect Dis. 2001 Dec;1(5):345-53
references: 11871807